Cantor Fitzgerald Brokers Cut Earnings Estimates for ARWR
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) - Investment analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for Arrowhead Pharmaceuticals in a report issued on Wednesday, September 10th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the biotechnology company wil
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) - Investment analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for Arrowhead Pharmaceuticals in a report issued on Wednesday, September 10th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the biotechnology company wil
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
